EC Number | Application | Comment | Organism |
---|---|---|---|
1.6.5.2 | medicine | activation of antitumor prodrugs | Mus musculus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.6.5.2 | - |
Mus musculus |
1.6.5.2 | - |
Homo sapiens |
1.6.5.2 | - |
Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.6.5.2 | 3,3'-methylene-bis(4-hydroxycoumarin) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-methylene-bis(4-hydroxycoumarin) | - |
Mus musculus | |
1.6.5.2 | 3,3'-methylene-bis(4-hydroxycoumarin) | - |
Rattus norvegicus | |
1.6.5.2 | 5,7-dihydroxyflavone | - |
Homo sapiens | |
1.6.5.2 | 5,7-dihydroxyflavone | - |
Mus musculus | |
1.6.5.2 | 5,7-dihydroxyflavone | - |
Rattus norvegicus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.6.5.2 | 0.025 | - |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione | - |
Homo sapiens | |
1.6.5.2 | 0.027 | - |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione | - |
Rattus norvegicus | |
1.6.5.2 | 0.04 | - |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione | - |
Mus musculus | |
1.6.5.2 | 0.1 | - |
NADH | - |
Homo sapiens | |
1.6.5.2 | 0.11 | - |
NADH | - |
Rattus norvegicus | |
1.6.5.2 | 0.12 | - |
NADH | - |
Mus musculus | |
1.6.5.2 | 0.84 | - |
5-(aziridin-1-yl)-4-hydroxylamino-2-benzamide | - |
Rattus norvegicus | |
1.6.5.2 | 1.28 | - |
5-(aziridin-1-yl)-4-hydroxylamino-2-benzamide | - |
Mus musculus | |
1.6.5.2 | 1.37 | - |
5-(aziridin-1-yl)-4-hydroxylamino-2-benzamide | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.6.5.2 | Homo sapiens | - |
- |
- |
1.6.5.2 | Mus musculus | - |
- |
- |
1.6.5.2 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.6.5.2 | recombinant enzyme | Mus musculus |
1.6.5.2 | recombinant enzyme | Homo sapiens |
1.6.5.2 | recombinant enzyme | Rattus norvegicus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.6.5.2 | 2-methyl-1,4-naphthoquinone + NAD(P)H | - |
Mus musculus | 2-methyl-1,4-naphthoquinol + NAD(P)+ | - |
? | |
1.6.5.2 | 2-methyl-1,4-naphthoquinone + NAD(P)H | - |
Rattus norvegicus | 2-methyl-1,4-naphthoquinol + NAD(P)+ | - |
? | |
1.6.5.2 | 2-methyl-1,4-naphthoquinone + NAD(P)H | involved in the process of reductive activation of several cytotoxic antitumor quinones, such as mitomycins, anthracyclines and azaridinylbenzoquinones | Homo sapiens | 2-methyl-1,4-naphthoquinol + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione + NAD(P)H | - |
Mus musculus | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-diol + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione + NAD(P)H | - |
Homo sapiens | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-diol + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione + NAD(P)H | - |
Rattus norvegicus | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-diol + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide + NAD(P)H | - |
Mus musculus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide + NAD(P)H | - |
Homo sapiens | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide + NAD(P)H | - |
Rattus norvegicus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + NAD(P)+ | - |
? | |
1.6.5.2 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide + reduced dihydronicotineamide riboside | - |
Mus musculus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + oxidized dihydronicotineamide riboside | - |
? | |
1.6.5.2 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide + reduced dihydronicotineamide riboside | - |
Homo sapiens | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + oxidized dihydronicotineamide riboside | - |
? | |
1.6.5.2 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide + reduced dihydronicotineamide riboside | - |
Rattus norvegicus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + oxidized dihydronicotineamide riboside | - |
? | |
1.6.5.2 | menadione + NADH + H+ | - |
Mus musculus | menadiol + NAD+ | - |
r |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.6.5.2 | 0.07 | - |
5,7-dihydroxyflavone | - |
Homo sapiens | |
1.6.5.2 | 0.08 | - |
5,7-dihydroxyflavone | - |
Rattus norvegicus | |
1.6.5.2 | 0.68 | - |
5,7-dihydroxyflavone | - |
Mus musculus |